Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova rises as US FDA inspection yields no action

** Shares of Jubilant Pharmova  JUBA.NS  rise as much as
4.1%, last up 1.2% to 1,030 rupees
    ** Co says U.S. FDA's inspection of its U.S. contract
manufacturing facility classified as "Voluntary Action
Indicated"
    ** VAI indicates the agency is not prepared to take or
recommend any administrative or regulatory action, per the U.S.
FDA website
    ** Stock on track to rise in six out of seven straight
sessions if trend holds
    ** JUBA up 89% YTD

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))

Recent news on Jubilant Pharmova

See all news